Study number 8539-173
Women Currently Breastfeeding!
Dates
Mar 17 2026-Mar 19 2026
Location
Madison, Wisconsin
Age
18-45
Gender
Females
Smoker
No
Compensation
$3,125
Group
C2
Study Details
This study drug is a penicillin class antibiotic that has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of female patients 18 years of age and older with uncomplicated urinary tract infection (UTIs) caused by certain types of bacteria.
Madison, WI is now recruiting Women Currently Breastfeeding, ages 18-45
Refer a friend & receive $500 per qualified referral
Women Eligibility Criteria
- Women must be 6 weeks postpartum at the time of screening.
Body Mass Index
- Participants must have a BMI of:
- 18-40
Smoking criteria
- Smoking is not allowed. You will be tested for cotinine at screening.
Screening procedures
- Screening procedures for this study may include:
- Vitals
- Physical examination
- Electrocardiogram (ECG)
- Collection of blood samples
- Drug and Alcohol testing
Additional Details
C2
Check-in: Mar 17
Check-out: Mar 19
Follow-up call: Mar 23